HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Laser Surgeon Says Home-Use Aesthetic Devices Could Fill Niche

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Dermatologist and laser surgeon Arielle Kauvar is not threatened by home-use aesthetic devices - touted as cheaper and more convenient than professional treatments - but believes there could be a viable market for them as "maintenance" products

You may also be interested in...



Two Acne-Zapping Smartphone Apps Shut Down; FTC On Lookout For Others

Smartphones can do a lot of things, but curing acne is likely not one of them.

Two Acne-Zapping Smartphone Apps Shut Down; FTC On Lookout For Others

Smartphones can do a lot of things, but curing acne is likely not one of them.

TRIA Enhances Home Hair-Removal Device, Lowers Price In Time For Holidays

TRIA Beauty has upgraded its laser hair-removal device, knocked $200 off the price and launched a multimedia marketing campaign to entice shoppers this holiday season

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer

Over The Counter 22 Apr 2024: Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo PR's Anita Nahal

See All
UsernamePublicRestriction

Register

RS016440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By